In this longitudinal study, we showed that anti–PD-1 accelerated T1D onset, increased glutamic acid decarboxylase–reactive T cell frequency in spleen, and precipitated destruction of β cells, triggering high glucose levels and pancreatic islet reduction. This evidence concerns the gene PDCD1 and type 1 diabetes mellitus.